INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
BL

Burroughs Amy L.

Director, Chief Executive OfficerCIK 0001872564

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 2
Max Insider Score18
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Grant or award · 10b5-1 plan
A—
150.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Terns Pharmaceuticals, Inc.Director, Chief Executive Officer · Jan 16, 2026
6
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M
$126K
27.1K sh
Jan 15, 2026
Jan 16, 2026
traded Jan 15, 2026
+1d
SEC FORM 4

Evidence

6
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$126K
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

2
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$68K
14.6K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

18
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$2.27M
61.2K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Grant or award · 10b5-1 plan
A—
300.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC FORM 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
27.1K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

0
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

11
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$282K
7,521 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence